Drug Profile
Amoxicillin extended-release - MiddleBrook
Alternative Names: Amoxicillin PULSYS; APC-111; APC-231; MoxatagLatest Information Update: 23 Dec 2021
Price :
$50
*
At a glance
- Originator Advancis Pharmaceutical
- Developer MiddleBrook Pharmaceuticals
- Class Antibacterials; Penicillins; Small molecules
- Mechanism of Action Cell wall inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Pharyngitis; Tonsillitis